AlzeCure Pharma

AlzeCure | Life Science Summit 2026

Xbrane clears the FDA, BioInvent seeks 430 Mkr and Genmab keeps surging – the Nordic Pulse | 2026:44

Report from BioJapan: Nordic biotech on the long game in Japan

Japan is one of the world's largest pharmaceutical...

A quarter of billion-euro licences, a Novo comeback and a flat Nordic index – the State of Nordic BioPharma | 2026:Q3

BioArctic’s home-run, a third win for Astra’s Tezspire and a path to phase III for Lytix – the Nordic Pulse | 2026:35

De största affärerna inom nordisk life science 2026

Ett svenskt Alzheimerbolag dubblerade sin egen miljardaffär på...

AstraZeneca fires three barrels, Implantica enters the US – the Nordic Pulse | 2026:34

Demant raises the bar, XVIVO clears hearts and Zealand cashes in – the Nordic Pulse | 2026:33

AlzeCure får 12 miljoner USD upfront från QuantumCell

AlzeCure Pharma har mottagit hela upfrontbetalningen om 12...

Novo raises outlook, BioInvent breaks through, Nordics tread water – the Nordic Pulse | 2026:32

AlzeCure fullföljer avtal med QuantumCell genom riktad emission

Som ett led i det tidigare kommunicerade licensavtalet...